Replies to post #236 on MEI Pharma, Inc. (MEIP)

[murocman]

Yes it is....post news sell-off that is typical. Once it finds a floor, I'll buy back in as it should run again into full top line results.

Wildcard would be a buyout/expanded partnership before that event.

GLTA,

Murocman